Chandra Panchal

Dr. Panchal is the Founder of Axcelon Biopolymers Corp., a biotechnology company where he is Chairman, CEO and CSO. From 1989 to 1999 he was Co-Founder, President, and CEO of Procyon Biopharma Inc., which he took public on the TSXV in 1998 and later on the TSX in 2000. Thereafter, Dr. Panchal was CSO at Procyon until its merger with Cellpep, Inc (2006). He was then Senior Executive VP of Business Development at the merged entity, Ambrilia Biopharma Inc. During his term at Procyon and Ambrilia, he led several licensing and M&A transactions with pharmaceutical and biotechnology companies relating to cancer and HIV drugs developed by the company. Dr. Panchal sits on the boards of Canadian Oil Recovery & Remediation Enterprises (TSXV:CVR), Avicanna Inc.(as Chairman) (TSX:AVCN) and was until recently, a board member of MaRS Innovation, Pure Global (TSX.V:PURE), and Avivagen (TSXV:VIV). Dr. Panchal obtained a Ph.D. in biochemical engineering from Western University.